| Name | Title | Contact Details |
|---|
CODAC Behavioral Health Services of Pima County is a nonprofit 501(c)(3) organization that provides mental health and substance use disorder treatment and prevention programs to children, adults and families in Pima County. It is CODAC’s mission to work collaboratively with individuals, families and organizations to eliminate the harmful effects of substance use disorders, mental illness and abuse on their lives and families. CODAC was founded in 1970 and has evolved into a comprehensive service provider with a full continuum of mental health and substance use disorder treatment programs for youth (ages 12-17), young adults (ages 18-21) and adults (ages 22+) and their families at 10 conveniently located sites. CODAC’s prevention services are community-based and recognized as best-practices for preventing risky behaviors in Pima County youth and families.
Physicians Choice Home Health is a Torrance, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Motility Incorporated is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At Indi we believe that a systems-based approach is necessary to understand complex diseases and improve health. Our mission is to dramatically improve diagnosis and management of complex diseases by building advanced molecular diagnostics and creating new diagnostic technologies. We seek to understand the complex biological systems from which diseases arise so that we can determine which combinations of biomarkers have the greatest diagnostic power. Then we build assays capable of measuring hundreds of proteins at a time, for more precise detection and management of disease. Our end goal is to create large-scale systems medicine diagnostics that can gather a wealth of information – and then make sense of that information so that physicians can better diagnose disease.
Repertoire Immune Medicines is working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions, and infectious diseases. Repertoire scientists created and developed a suite of technologies for its DECODE discovery and DEPLOY product platforms that allow in-depth characterization of the immune synapse and the ability to rationally design, and clinically develop, multi-clonal immune medicines. The company is currently conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.